Depression Center Colloquium Series
For health professionals and researchers with an interest in depression and related illnesses.
All programs run from 11:45 AM - 1:30 PM in the Rachel Upjohn Building auditorium (Garden Level). There is no charge for attendance, and lunch is provided for those who register. For each colloquium, please arrive at 11:45 AM for lunch. The first speaker will begin promptly at 12 PM.
Schedule
Friday, February 5, 2010
Depression in Physicians and Medical Students
- Liselotte N. Dyrbye, M.D., Assistant Professor of Medicine, Department of Internal Medicine, Mayo Clinic
- Thomas Schwenk, M.D., George A. Dean, M.D. Chair of Family Medicine; Professor, Department of Family Medicine, University of Michigan School of Medicine; Associate Director, University of Michigan Depression Center
Friday, April 23, 2010
The Role of Pro-Inflammatory Cytokines at the Depression-Pain Interface
- Andrew H. Miller, M.D., William P. Timmie Professor of Psychiatry and Behavioral Sciences, Director, Psychiatric Oncology, Winship Cancer Institute, Emory University School of Medicine
- Daniel Clauw, M.D., Professor, Department of Internal Medicine and Director, Center for the Advancement of Clinical Research (CACR), University of Michigan School of Medicine
MAY TBD
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Michigan Medical School designates this educational activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This program is approved by the Michigan Social Work Continuing Education Collaborative for 1.5 each CE Clock Hours. Course approval is #051407-07
The University of Michigan Depression Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The University of Michigan Depression Center maintains responsibility for this program and its content.
The Colloquium Series is made possible by an educational grant from AstraZeneca.
